Video Experimental Relacionado

Updated: Feb 12, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Estrategias de descubrimiento guiadas por la estructura para inhibidores de moléculas pequeñas dirigidos a Trop2

¹Department of Biology Education, Daegu University, 201, Daegudae-ro, Gyeongsan-si, Gyeongsangbuk-do 38453, Republic of Korea.

Bulletin du cancer

|February 10, 2026

Resumen

Las pequeñas moléculas dirigidas al antígeno de la superficie celular del trofoblasto 2 (Trop2) son prometedoras para la terapia del cáncer. Las estrategias basadas en la estructura y los métodos avanzados de detección son clave para desarrollar inhibidores de Trop2 de próxima generación.

Área de la Ciencia:

Oncología Oncología.
Descubrimiento de Drogas Descubrimiento de Drogas
Biología Molecular Biología Molecular

Sus antecedentes:

El antígeno de la superficie celular del trofoblasto 2 (Trop2) se sobreexpresa en los cánceres epiteliales, impulsando el crecimiento y la resistencia del tumor.
Los conjugados anticuerpo-fármaco (ADC) dirigidos a Trop2 muestran éxito, pero tienen limitaciones como toxicidad y resistencia.

Objetivo del estudio:

Revisar los avances recientes en los inhibidores de moléculas pequeñas dirigidos a Trop2.
Centrarse en estrategias basadas en la estructura para el desarrollo de inhibidores de Trop2.
Explorar nuevas modalidades terapéuticas más allá de los ADC.

Principales métodos:

Resumiendo los mecanismos de señalización oncogénicos de Trop2 (por ejemplo, proteólisis intramembrana, estabilización de la β-catenina).
Identificación de dominios estructurales clave (bucle TY, cresta ND-CD, sitios de fosforilación) para la unión de moléculas pequeñas.
Examinar compuestos naturales (por ejemplo, Bruceine D) y flujos de trabajo computacionales / experimentales (acoplamiento, CETSA, cribado de IA).

Principales resultados:

Se identifican dominios estructurales clave de Trop2 como potenciales bolsas de unión para los inhibidores de moléculas pequeñas.
Bruceine D sirve como un estudio de caso para un modulador Trop2-ICD natural.
Los enfoques computacionales y experimentales integrados facilitan el diseño racional de fármacos.

Conclusiones:

Los inhibidores de moléculas pequeñas representan una alternativa prometedora a los ADC para la terapia contra el cáncer dirigida a Trop2.
El diseño basado en la estructura, el descubrimiento basado en fragmentos y la detección guiada por IA son cruciales para optimizar los inhibidores de Trop2.
Estas estrategias ofrecen un marco para el desarrollo de la próxima generación de terapias Trop2.

Palabras clave:

Inhibidores de las pequeñas moléculas.Trop2 también.La señalización de la β-catenina.

Más Videos Relacionados

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Videos de Conceptos Relacionados

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Additional Subnuclear Structures

Additional Subnuclear Structures

The eukaryotic nucleus is a double membrane-bound organelle that contains nearly all of the cell’s genetic material in the form of chromosomes. It is rightly called the “brain” of the cell as it shoulders the responsibility of responding to various physiological processes, stress, altered metabolic conditions, and other cellular signals.
The nucleus contains many membrane-less subnuclear organelles or nuclear bodies, such as nucleoli, Cajal bodies, speckles,...

Molecules and Compounds

Molecules and Compounds

Atoms and Molecules

Structure of Lipids

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.